Molecular structure of Bismuth(III) subsalicylate, CAS Number: 14882-18-9
Bismuth(III) subsalicylate (CAS 14882-18-9)
Alternate Names:
Bismuth oxysalicylate, Bismuth subsalicylate, Bismuth(III) salicylate basic
Application:
Bismuth(III) subsalicylate is an antiinflammatory
CAS Number:
14882-18-9
Molecular Weight:
362.09
Molecular Formula:
C7H5BiO4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Bismuth(III) subsalicylate functions as an antacid and anti-diarrheal agent. It works by forming a protective coating on the lining of the stomach and intestines, which helps to reduce irritation and inflammation. Bismuth(III) subsalicylate also has the ability to inhibit the growth of certain bacteria, which can contribute to its anti-diarrheal effects. At the molecular level, bismuth(III) subsalicylate interacts with the mucosal lining of the gastrointestinal tract, forming a barrier that helps to alleviate symptoms of indigestion and diarrhea.
Bismuth(III) subsalicylate (CAS 14882-18-9) References
- Towards a molecular model for bismuth(III) subsalicylate. Synthesis and solid-state structure of [Bi(Hsal)3(bipy)(C7H8]2 and [Bi(Hsal)(sal)(1,10-phenanthroline)(C7H8]2. | Thurston, JH., et al. 2002. Chem Commun (Camb). 2834-5. PMID: 12478770
- Copolymerizations of epsilon-caprolactone and glycolide-a comparison of tin(II)octanoate and bismuth(III)subsalicylate as initiators. | Kricheldorf, HR. and Rost, S. 2005. Biomacromolecules. 6: 1345-52. PMID: 15877351
- Intermittent hypoxia in rats increases myogenic tone through loss of hydrogen sulfide activation of large-conductance Ca(2+)-activated potassium channels. | Jackson-Weaver, O., et al. 2011. Circ Res. 108: 1439-47. PMID: 21512160
- Grafting of a model protein on lactide and caprolactone based biodegradable films for biomedical applications. | Larrañaga, A., et al. 2014. Biomatter. 4: e27979. PMID: 24509417
- Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease. | Mottawea, W., et al. 2016. Nat Commun. 7: 13419. PMID: 27876802
- Advances in Solid-State Transformations of Coordination Bonds: From the Ball Mill to the Aging Chamber. | Mottillo, C. and Friščić, T. 2017. Molecules. 22: PMID: 28106754
- NOSH-NBP, a Novel Nitric Oxide and Hydrogen Sulfide- Releasing Hybrid, Attenuates Ischemic Stroke-Induced Neuroinflammatory Injury by Modulating Microglia Polarization. | Ji, J., et al. 2017. Front Cell Neurosci. 11: 154. PMID: 28603491
- Magnetically driven microfluidics for isolation of circulating tumor cells. | Luo, L. and He, Y. 2020. Cancer Med. 9: 4207-4231. PMID: 32325536
- Fructose Intake Impairs the Synergistic Vasomotor Manifestation of Nitric Oxide and Hydrogen Sulfide in Rat Aorta. | Berenyiova, A., et al. 2021. Int J Mol Sci. 22: PMID: 33946264
- Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760-Benefit or Detriment in Essential Hypertension? | Berenyiova, A., et al. 2021. Biomedicines. 10: PMID: 35052717
- A Comprehensive Investigation of the Structural, Thermal, and Biological Properties of Fully Randomized Biomedical Polyesters Synthesized with a Nontoxic Bismuth(III) Catalyst. | Domańska, IM., et al. 2022. Molecules. 27: PMID: 35164403
Inhibitor of:
Ajuba, Gastrokine 1, GIF, KA2, KMO, Mcsp, Metallothionein 1B, Metallothionein 1H, MOSC1, Rotavirus capsid, Salmonella LPS, and TrxR1.Activator of:
1700065O13Rik, Gastrokine 2, Shigatoxin, and VacA.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Bismuth(III) subsalicylate, 100 g | sc-227416 | 100 g | $30.00 |